Jim Simons 2seventy Bio, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$3.14 - $11.2 $310,354 - $1.11 Million
98,839 New
98,839 $387,000
Q1 2023

May 12, 2023
BUY
$9.21 - $14.98 $342,612 - $557,256
37,200 Added 192.75%
56,500 $576,000
Q4 2022

Feb 13, 2023
BUY
$8.57 - $17.0 $165,401 - $328,100
19,300 New
19,300 $181,000

Others Institutions Holding TSVT

# of Institutions
126
Shares Held
45.6M
Call Options Held
122K
Put Options Held
19.8K
View Full List

About 2seventy bio, Inc.

TSVT Quotes by TradingView
  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email